Rich Pharmaceuticals, Inc.is committed to good corporate citizenship. Our policy is to conduct our business affairs honestly and ethically. Our Code of Conduct (“Code”) provides a general statement of Rich Pharmaceuticals, Inc. expectations regarding the ethical standards to which each director, employee, including officers, and contractors should adhere while acting on Rich Pharmaceuticals, Inc. behalf.
If you become aware of conduct by an officer, director, employee or contract worker that you believe in good faith is a potential violation of the Code, you should promptly notify Rich Pharmaceuticals legal department. If you wish to report such matters anonymously, you may describe the concern or complaint to the legal department at firstname.lastname@example.org Employees are protected by law from retaliation for reporting in good faith possible issues or concerns under the Code.
Rich Pharmaceuticals Explains How Targeted Immunotherapy Aids in the Treatment and Recovery of AML Patients
Rich Pharmaceuticals’ Study Drug RP-323 (TPA) is a Potential Therapeutic Agent for the Treatment of Hodgkin’s Lymphoma
Rich Pharmaceuticals’ Study Drug RP-323 (TPA) Elevates White Blood Cells (WBCs) Which Play a Vital Role Fighting Infections, and in Immunotherapy